Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor

被引:118
|
作者
Tateishi, Y
Kawabe, Y
Chiba, T
Murata, S
Ichikawa, K
Murayama, A
Tanaka, K
Baba, T
Kato, S
Yanagisawa, J
机构
[1] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan
[2] Tokyo Metropolitan Inst Med Sci, Bunkyo Ku, Tokyo 113, Japan
[3] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan
[4] Japan Sci & Technol, SORST, Kawaguchi, Saitama, Japan
[5] Ankhs Inc, Tsukuba, Ibaraki, Japan
来源
EMBO JOURNAL | 2004年 / 23卷 / 24期
关键词
estrogen receptor; nuclear receptors transcription; ubiquitination;
D O I
10.1038/sj.emboj.7600472
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent evidence indicates that the transactivation of estrogen receptor alpha (ERalpha) requires estrogen-dependent receptor ubiquitination and degradation. Here we show that estrogen-unbound (unliganded) ERalpha is also ubiquitinated and degraded through a ubiquitin-proteasome pathway. To investigate this ubiquitin-proteasome pathway, we purified the ubiquitin ligase complex for unliganded ERalpha and identified a protein complex containing the carboxyl terminus of Hsc70-interacting protein (CHIP). CHIP preferentially bound to misfolded ERalpha and ubiquitinated it to induce degradation. Ligand binding to the receptor induced the dissociation of CHIP from ERalpha. In CHIP-/- cells, the degradation of unliganded ERalpha was abrogated; however, estrogen-induced degradation was observed to the same extent as in CHIP+/+ cells. Our findings suggest that ERalpha is regulated by two independent ubiquitin-proteasome pathways, which are switched by ligand binding to ERalpha. One pathway is necessary for the transactivation of the receptor and the other is involved in the quality control of the receptor.
引用
收藏
页码:4813 / 4823
页数:11
相关论文
共 50 条
  • [41] Regulation of follitropin receptor cell surface residency by the ubiquitin-proteasome pathway
    Cohen, BD
    Bariteau, JT
    Magenis, LM
    Dias, JA
    ENDOCRINOLOGY, 2003, 144 (10) : 4393 - 4402
  • [42] Modulation of autophagy and ubiquitin-proteasome pathways during ultra-endurance running
    Jamart, Cecile
    Francaux, Marc
    Millet, Guillaume Y.
    Deldicque, Louise
    Frere, Delphine
    Feasson, Leonard
    JOURNAL OF APPLIED PHYSIOLOGY, 2012, 112 (09) : 1529 - 1537
  • [43] Estrogen receptor-KRAB chimeras are potent ligand-dependent repressors of estrogen-regulated gene expression
    de Haan, G
    Chusacultanachai, S
    Mao, CJ
    Katzenellenbogen, BS
    Shapiro, DJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) : 13493 - 13501
  • [44] LIGAND-DEPENDENT REPRESSION OF THE ERYTHROID TRANSCRIPTION FACTOR GATA-1 BY THE ESTROGEN-RECEPTOR
    BLOBEL, GA
    SIEFF, CA
    ORKIN, SH
    MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (06) : 3147 - 3153
  • [45] Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts
    Bodine, PVN
    Harris, HA
    Komm, BS
    ENDOCRINOLOGY, 1999, 140 (06) : 2439 - 2451
  • [46] MODULATION OF TRANSCRIPTIONAL ACTIVATION BY LIGAND-DEPENDENT PHOSPHORYLATION OF THE HUMAN ESTROGEN RECEPTOR-A/B REGION
    ALI, S
    METZGER, D
    BORNERT, JM
    CHAMBON, P
    EMBO JOURNAL, 1993, 12 (03): : 1153 - 1160
  • [47] Formation of distinct inclusion bodies by inhibition of ubiquitin-proteasome and autophagy-lysosome pathways
    Lee, Junho
    Yang, Kyu-Hwan
    Joe, Cheol O.
    Kang, Seok-Seong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 404 (02) : 672 - 677
  • [48] Activin-βC modulates cachexia by repressing the ubiquitin-proteasome and autophagic degradation pathways
    Marino, Francesco Elia
    Risbridger, Gail
    Gold, Elspeth
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2015, 6 (04) : 365 - 380
  • [49] Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer
    Ioannis A Voutsadakis
    World Journal of Gastrointestinal Oncology, 2010, (05) : 235 - 241
  • [50] Abnormal lysosomal and ubiquitin-proteasome pathways in 19p13.3 distal myopathy
    Di Blasi, C
    Moghadaszadeh, B
    Ciano, C
    Negri, T
    Giavazzi, A
    Cornelio, F
    Morandi, L
    Mora, M
    ANNALS OF NEUROLOGY, 2004, 56 (01) : 133 - 138